卷 14, 编号 3 (2012)
- 年: 2012
- 文章: 19
- URL: https://journals.rcsi.science/1815-1434/issue/view/1674
Articles
22 sentyabrya 2012 g. sostoyalsya press-brifing, posvyashchennyy roli targetnoy terapii v preodolenii lekarstvennoy rezistentnosti pri lechenii metastaticheskogo raka molochnoy zhelezy (mRMZh) i, v chastnosti, predstavleniyu obshchestvennosti novykh zaregistrirovannykh pokazaniy dlya primeneniya preparata Afinitor pri mRMZh
Journal of Modern Oncology. 2012;14(3):5-6
5-6
6-9 sentyabrya 2012 g. v Marsele sostoyalsya 10-y kongress Evropeyskoy assotsiatsii po neyroonkologii (EANO)
Journal of Modern Oncology. 2012;14(3):7-8
7-8
Vmeste k novym dostizheniyam v lechenii limfoproliferativnykh zabolevaniyKlinicheskiy limforum, Irkutsk, 23-24 avgusta 2012 g., i novye plany na 2012- 2013 gg.
Journal of Modern Oncology. 2012;14(3):9-10
9-10
Internet-konferentsiya «Follikulyarnye limfomy»
Journal of Modern Oncology. 2012;14(3):10-
10-
Rakovye registry v mire. Chast' 3. PHAROS - Gollandskiy populyatsionnyy registr onkogematologicheskikh bol'nykh
Journal of Modern Oncology. 2012;14(3):11-12
11-12
Opyt primeneniya bendamustina u patsientov s retsidivom khronicheskogo limfoleykoza v rezhime monoterapii v ambulatornykh usloviyakh
Journal of Modern Oncology. 2012;14(3):13-15
13-15
Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay)
Journal of Modern Oncology. 2012;14(3):16-19
16-19
Podderzhivayushchaya terapiya pri metastaticheskom kolorektal'nom rake: odin iz variantov vybora ili novyy standart lecheniya?
Journal of Modern Oncology. 2012;14(3):20-24
20-24
Podderzhivayushchaya terapiya nemelkokletochnogo raka legkogo
Journal of Modern Oncology. 2012;14(3):25-31
25-31
Mesto khimioterapii i gormonoterapii vo 2-y linii lecheniya kastratsionno-rezistentnogo raka predstatel'noy zhelezy
Journal of Modern Oncology. 2012;14(3):32-36
32-36
Fulvestrant - endokrinnaya terapiya rasshirennogo spektra deystviya
Journal of Modern Oncology. 2012;14(3):37-40
37-40
Ispol'zovanie pokazatelya effektivnosti zatrat pri kompleksnoy farmakoekonomicheskoy otsenke dorogostoyashchikh meditsinskikh tekhnologiy. Primer bevatsizumaba
Journal of Modern Oncology. 2012;14(3):41-44
41-44
Sobstvennyy opyt ispol'zovaniya peroral'noy formy vinorelbina
Journal of Modern Oncology. 2012;14(3):45-49
45-49
Novyy vzglyad na biologicheskie osobennosti pervichnoy ekstranodal'noy diffuznoy V-krupnokletochnoy limfomy
Journal of Modern Oncology. 2012;14(3):50-56
50-56
Prognozirovanie zabolevaemosti rakom molochnoy zhelezy s vydeleniem populyatsii patsientov s giperekspressiey HER2 v Sibirskom federal'nom okruge
Journal of Modern Oncology. 2012;14(3):57-59
57-59
Vozmozhnosti khirurgicheskogo lecheniya mestnorasprostranennogo i retsidivnogo raka rotoglotki
Journal of Modern Oncology. 2012;14(3):60-65
60-65
Perspektivy primeneniya ademetionina v komplekse intensivnoy terapii bol'nykh s ostroy pechenochnoy nedostatochnost'yu: vzglyad reanimatologa
Journal of Modern Oncology. 2012;14(3):66-68
66-68
Variant techeniya kholangiokartsinomy: obzor literatury i sobstvennoe klinicheskoe nablyudenie
Journal of Modern Oncology. 2012;14(3):69-76
69-76
Khimioluchevaya terapiya ploskokletochnogo mestnorasprostranennogo anal'nogo raka (klinicheskiy sluchay)
Journal of Modern Oncology. 2012;14(3):77-80
77-80